Navigation Links
Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
Date:11/4/2010

ncer metastatic to the liver 196

SWOT analysis 197

Datamonitor drug assessment scorecard for ThermoDox 197

Clinical and commercial attractiveness 198

Phase I results are insufficient to judge ThermoDox's commercial potential 198

Most hepatocellular carcinoma patients present with disease that is too advanced for radiofrequency ablation 199

In order to optimize ThermoDox's commercial potential, Celsion should seek a partner experienced in the oncology market 199

Satisfaction of unmet needs 199

Forecasts to 2019 200

Sutent (sunitinib; Pfizer) 200

Drug overview 200

Drug profile 201

Key historical events 201

Clinical trial data 202

Phase II studies show evidence of some antitumor activity, although toxicity and fatalities associated with Sutent are a concern 203

SWOT analysis 204

Datamonitor drug assessment scorecard for Sutent 205

Clinical and commercial attractiveness 205

Sutent will have to show significantly superior survival benefits in order to effectively compete with

Nexavar in the advanced hepatocellular carcinoma population and overcome negative Phase II results 205

Other late-phase pipeline agents also pose a competitive threat to Sutent 206

Altering Sutent's target patient population in hepatocellular carcinoma could be the key to commercial success 206

Pfizer's growing position in the oncology market will assist in Sutent's potential success 206

Satisfaction of unmet needs 206

Forecasts to 2019 207

7. Pancreatic Cancer 209

Key findings 209

Disease overview 209

Definition 209

Pancreatic cancer represents a major health issue in the developed world 209

Patient segmentation 210

The TNM staging system does not take resectability of a tumor into account, therefore an alternative clinical staging system is often used 210

Epidemiology 210


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
2. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
3. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
6. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
7. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
8. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
10. Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
11. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... YORK , Oct. 30, 2014  The number ... States is growing steadily, thanks to drug ... as a result of the economic downturn, retail clinic ... a year of opportunities, as the number of retail ... researcher,s report, Retail Clinics Market Overview and 2014 ...
(Date:10/30/2014)... Oct. 30, 2014 Molecular Profiles Ltd., a ... ) and Maryland -based Xceleron have ... efficiency during clinical development that will be launched at ... week. This partnership extends Molecular Profiles, new ... launched earlier this month. The company also has complementary ...
(Date:10/30/2014)... Oct. 30, 2014  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced an upcoming ... drug candidate, aldoxorubicin.  The presentation, titled, "Drug Conjugates ... be given by Sant P. Chawla , ... and principal investigator of the Company,s ongoing global, ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
... April 26 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ... calls focused on the drugs in Isis, development pipeline.  The second call of ... Wednesday, April 28, 2010 at 12:00 p.m. ET .  This ... , , ...
... , TITUSVILLE, N.J. , April 26 The Court ... Pediatrics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., to overturn a 2009 decision ... for CONCERTA (methylphenidate HCl) Extended-Release Tablets CII is invalid and not infringed ... , In ...
Cached Medicine Technology:Isis Pharmaceuticals to Discuss Its Metabolic Franchise in a Conference Call on Wednesday, April 28 2Isis Pharmaceuticals to Discuss Its Metabolic Franchise in a Conference Call on Wednesday, April 28 3CONCERTA(R) Patent Appeal Denied 2CONCERTA(R) Patent Appeal Denied 3
(Date:10/30/2014)... Five months after their expansion, the ... announces new branding and a website to accompany their ... David Mepham’s promotion to name partner earlier this year, ... include Mepham’s name and better reflect their combined litigation ... the decision to implement new branding reflects Hodgkinson Street ...
(Date:10/30/2014)... Tara Haelle HealthDay Reporter ... More than 100 genes have been identified that appear ... And researchers say they are on their way ... contribute to the disorder. Autism spectrum disorders include ... social difficulties and repetitive behaviors. An estimated one in ...
(Date:10/30/2014)... October 30, 2014 Global prebiotics market ... according to a new study by Grand View Research, ... demand for sugar and fat free products owing to ... demand for prebiotics over the forecast period. , View ... , Food & beverage was the largest application segment ...
(Date:10/30/2014)... The Woodlands, TX (PRWEB) October 30, 2014 ... hospital system, released today its 2014 third quarter ... hospitals across Texas boasted infection rates of only ... also reported patient satisfaction scores exceeding 98 percent. ... this past quarter, which included rising satisfaction scores,” ...
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... lots of milk could be bad for your health, a ... calcium in milk can help strengthen bones and prevent osteoporosis. ... to recommend milk as part of a healthy diet. ... milk did not protect men or women from bone fractures, ...
Breaking Medicine News(10 mins):Health News:Hodgkinson Street Mepham Rebrands 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3
... get ready for a colonoscopy , , SUNDAY, Nov. 16 (HealthDay ... colonoscopy than men, a new study suggests. , Patients ... in the procedure, in which a doctor uses a flexible ... length of the colon. This poses problems for women, who ...
... Trees, parks get inner city kids moving, study finds , , ... of trees, help inner city kids keep excess pounds at ... our own, has provided snapshots in time, and shown that ... the lower the risk of obesity. Our new study of ...
... controversial documentary about a home-schooled teen boy who sets out to investigate ... the world,s simplest cure for cancer premieres Friday in New York City. ... ... journey of a boy who sets out to investigate the direct link ...
... such a breed doesn,t exist since allergens are also in ... Barack Obama has inspired throngs around the world to say, ... a hypoallergenic dog for the White House, allergists are saying, ... thing as a hypoallergenic dog," said Dr. Jonathan Field, emeritus ...
... Thousands of the world,s top scientists and clinicians in ... latest research at the 58th Annual Meeting of The ... on November 11-15, 2008. , A number of ... provide information about important new research findings that advance ...
... gym-goer, studies show , , FRIDAY, Nov. 14 (HealthDay News) -- Elite ... or sports drink soon after a workout. , But for mere ... in check or stave off heart disease -- adding calories right ... researchers say. , "If people are going to go out and ...
Cached Medicine News:Health News:Greener Neighborhoods Mean Slimmer Children 2Health News:THE CURE FOR CANCER? Documentary Film Defies the American Medical Community's Prescribed Treatments for Cancer and Chronic Disease 2Health News:THE CURE FOR CANCER? Documentary Film Defies the American Medical Community's Prescribed Treatments for Cancer and Chronic Disease 3Health News:THE CURE FOR CANCER? Documentary Film Defies the American Medical Community's Prescribed Treatments for Cancer and Chronic Disease 4Health News:First Family Will Have Tough Time Finding Hypoallergenic Dog 2Health News:First Family Will Have Tough Time Finding Hypoallergenic Dog 3Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 2Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 3Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 4Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 5Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 6Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 7Health News:Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery 8Health News:Post-Workout Snack May Hamper Weight Loss 2Health News:Post-Workout Snack May Hamper Weight Loss 3
... to Z Drug Facts produced by ... on thousands of medications. It provides ... effect, drug interactions, patient information and ... reference for physicians, students, residents, pharmacists, ...
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... with Integrated Calculators, based on Davis's Drug ... advance in drug reference. DDGNIC contains the ... Guide (9th Edition) and has integrated calculation ... product merges many of the advantages of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: